301520 万邦医药
交易中 07-20 14:42:33
资讯
新帖
简况
7月17日万邦医药（301520）龙虎榜数据：机构净卖出2220.33万元
证券之星 · 07-17 17:47
7月17日万邦医药（301520）龙虎榜数据：机构净卖出2220.33万元
万邦医药（301520）披露股票交易异常波动及风险提示公告，7月16日股价上涨13.37%
证券之星 · 07-16
万邦医药（301520）披露股票交易异常波动及风险提示公告，7月16日股价上涨13.37%
万邦医药：推进核心管线创新药石杉碱甲控释片、签订渐冻症等新药合作协议的相关信息均为不实信息
格隆汇 · 07-16
万邦医药：推进核心管线创新药石杉碱甲控释片、签订渐冻症等新药合作协议的相关信息均为不实信息
7月15日万邦医药（301520）龙虎榜数据：机构净买入742.42万元
证券之星 · 07-15
7月15日万邦医药（301520）龙虎榜数据：机构净买入742.42万元
万邦医药(301520)7月10日股东户数1.77万户，较上期增加65.3%
证券之星 · 07-15
万邦医药(301520)7月10日股东户数1.77万户，较上期增加65.3%
万邦医药：截止2026年7月10日，公司的股东人数为17,737户
证券之星 · 07-15
万邦医药：截止2026年7月10日，公司的股东人数为17,737户
股市必读：万邦医药（301520）登7月10日交易所龙虎榜
证券之星 · 07-13
股市必读：万邦医药（301520）登7月10日交易所龙虎榜
7月10日万邦医药（301520）龙虎榜数据：机构净卖出174.77万元
证券之星 · 07-10
7月10日万邦医药（301520）龙虎榜数据：机构净卖出174.77万元
万邦医药：本次交易不构成重大资产重组
证券之星 · 07-10
万邦医药：本次交易不构成重大资产重组
7月8日万邦医药（301520）龙虎榜数据：机构净卖出17.78万元
证券之星 · 07-08
7月8日万邦医药（301520）龙虎榜数据：机构净卖出17.78万元
7月7日万邦医药（301520）龙虎榜数据：机构净买入30.81万元
证券之星 · 07-07
7月7日万邦医药（301520）龙虎榜数据：机构净买入30.81万元
万邦医药：截止2026年6月30日，公司的股东人数为10,730户
证券之星 · 07-06
万邦医药：截止2026年6月30日，公司的股东人数为10,730户
股市必读：万邦医药（301520）登7月3日交易所龙虎榜
证券之星 · 07-06
股市必读：万邦医药（301520）登7月3日交易所龙虎榜
股市必读：万邦医药（301520）登7月1日交易所龙虎榜
证券之星 · 07-02
股市必读：万邦医药（301520）登7月1日交易所龙虎榜
万邦医药（301520）披露公司完成收购赛德盛股权工商变更登记，7月1日股价下跌4.62%
证券之星 · 07-01
万邦医药（301520）披露公司完成收购赛德盛股权工商变更登记，7月1日股价下跌4.62%
6月30日万邦医药（301520）龙虎榜数据：机构净买入954.57万元
证券之星 · 06-30
6月30日万邦医药（301520）龙虎榜数据：机构净买入954.57万元
【机构调研记录】富安达基金调研奥比中光、万邦医药
证券之星 · 06-30
【机构调研记录】富安达基金调研奥比中光、万邦医药
【机构调研记录】天治基金调研万邦医药
证券之星 · 06-30
【机构调研记录】天治基金调研万邦医药
【机构调研记录】前海开源基金调研绿联科技、万邦医药
证券之星 · 06-30
【机构调研记录】前海开源基金调研绿联科技、万邦医药
【私募调研记录】中欧瑞博调研万邦医药
证券之星 · 06-30
【私募调研记录】中欧瑞博调研万邦医药
加载更多
公司概况
公司名称：
安徽万邦医药科技股份有限公司
所属行业：
研究和试验发展
上市日期：
2023-09-25
主营业务：
安徽万邦医药科技股份有限公司的主营业务是药学和临床研究一站式服务。公司的主要产品是临床研究服务、药学研究服务。
发行价格：
67.88
{"stockData":{"symbol":"301520","market":"SZ","secType":"STK","nameCN":"万邦医药","latestPrice":56.86,"timestamp":1784529753000,"preClose":66.62,"halted":0,"volume":13045886,"delay":0,"changeRate":-0.1465,"floatShares":32698400,"shares":93171400,"eps":0.2611,"marketStatus":"交易中","change":-9.76,"latestTime":"07-20 14:42:33","open":56.12,"high":67.11,"low":56.05,"amount":795000000,"amplitude":0.166,"askPrice":56.86,"askSize":223,"bidPrice":56.79,"bidSize":32,"shortable":0,"etf":0,"ttmEps":0.2611,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1784530800000},"marketStatusCode":2,"adr":0,"adjPreClose":66.62,"symbolType":"stock","openAndCloseTimeList":[[1784511000000,1784518200000],[1784523600000,1784530800000]],"highLimit":73.28,"lowLimit":59.96,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":93171373,"isCdr":false,"pbRate":4.1,"roa":"--","peRate":217.770969,"roe":"--","epsLYR":0.55,"committee":-0.504762,"marketValue":5298000000,"turnoverRate":0.399,"status":1,"floatMarketCap":1859000000},"requestUrl":"/m/hq/s/301520","defaultTab":"news","newsList":[{"id":"2652010664","title":"7月17日万邦医药（301520）龙虎榜数据：机构净卖出2220.33万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652010664","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2652010664?lang=zh_cn&edition=full","pubTime":"2026-07-17 17:47","pubTimestamp":1784281622,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月17日公布的交易公开信息显示，万邦医药因日换手率达到30%的前5只证券登上龙虎榜。此次是近5个交易日内第5次上榜。截至2026年7月17日收盘，万邦医药报收于66.62元，下跌0.05%，换手率51.93%，成交量16.98万手，成交额11.2亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出2220.33万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700032806.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651193440","title":"万邦医药（301520）披露股票交易异常波动及风险提示公告，7月16日股价上涨13.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651193440","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651193440?lang=zh_cn&edition=full","pubTime":"2026-07-16 22:10","pubTimestamp":1784211023,"startTime":"0","endTime":"0","summary":"截至2026年7月16日收盘，万邦医药报收于66.65元，较前一交易日上涨13.37%，最新总市值为62.1亿元。近日，万邦医药发布《股票交易异常波动及风险提示公告》。公告显示，公司股票价格连续两个交易日涨幅偏离值累计超30%，属于异常波动。公司确认前期披露信息无误，近期经营正常，内外部环境无重大变化。公司未发布2026年半年度业绩预告，相关报告将于8月29日披露。公司股票短期内涨幅较大，存在非理性交易风险，提醒投资者注意投资风险。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600040037.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651441636","title":"万邦医药：推进核心管线创新药石杉碱甲控释片、签订渐冻症等新药合作协议的相关信息均为不实信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2651441636","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651441636?lang=zh_cn&edition=full","pubTime":"2026-07-16 20:00","pubTimestamp":1784203250,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["301520","BK0216","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651456793","title":"7月15日万邦医药（301520）龙虎榜数据：机构净买入742.42万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2651456793","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651456793?lang=zh_cn&edition=full","pubTime":"2026-07-15 17:28","pubTimestamp":1784107712,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月15日公布的交易公开信息显示，万邦医药因日涨幅达到15%的前5只证券，日换手率达到30%的前5只证券登上龙虎榜。此次是近5个交易日内第5次上榜。截至2026年7月15日收盘，万邦医药报收于58.79元，上涨20.0%，涨停，换手率54.06%，成交量17.68万手，成交额9.65亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入742.42万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500033369.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651560354","title":"万邦医药(301520)7月10日股东户数1.77万户，较上期增加65.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651560354","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651560354?lang=zh_cn&edition=full","pubTime":"2026-07-15 17:27","pubTimestamp":1784107620,"startTime":"0","endTime":"0","summary":"证券之星消息，近日万邦医药披露，截至2026年7月10日公司股东户数为1.77万户，较6月30日增加7007.0户，增幅为65.3%。在医疗服务行业个股中，万邦医药股东户数低于行业平均水平，截至7月10日，医疗服务行业平均股东户数为4.86万户。从股价来看，2026年6月30日至2026年7月10日，万邦医药区间涨幅为39.02%，在此期间股东户数增加7007.0户，增幅为65.3%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500033285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651443657","title":"万邦医药：截止2026年7月10日，公司的股东人数为17,737户","url":"https://stock-news.laohu8.com/highlight/detail?id=2651443657","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651443657?lang=zh_cn&edition=full","pubTime":"2026-07-15 11:37","pubTimestamp":1784086654,"startTime":"0","endTime":"0","summary":"证券之星消息，万邦医药(301520)07月15日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2026年七月 10日公司的股东总数是多少？谢谢万邦医药回复：尊敬的投资者您好！截止2026年7月10日，公司的股东人数为17,737户。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071500019211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651165032","title":"股市必读：万邦医药（301520）登7月10日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2651165032","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2651165032?lang=zh_cn&edition=full","pubTime":"2026-07-13 01:45","pubTimestamp":1783878314,"startTime":"0","endTime":"0","summary":"截至2026年7月10日收盘，万邦医药报收于45.18元，上涨8.61%，换手率46.06%，成交量15.06万手，成交额6.45亿元。当日关注点交易信息汇总：万邦医药因日换手率达30%登上龙虎榜，系近5个交易日内第5次上榜。股本股东变化：截至2026年6月30日，万邦医药股东户数增至1.07万户，较6月18日增长53.18%，户均持股由1.33万股降至8683.0股。户均持股数量由上期的1.33万股减少至8683.0股，户均持股市值为28.22万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300000890.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650018625","title":"7月10日万邦医药（301520）龙虎榜数据：机构净卖出174.77万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2650018625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650018625?lang=zh_cn&edition=full","pubTime":"2026-07-10 17:28","pubTimestamp":1783675707,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月10日公布的交易公开信息显示，万邦医药因日换手率达到30%的前5只证券登上龙虎榜。此次是近5个交易日内第5次上榜。截至2026年7月10日收盘，万邦医药报收于45.18元，上涨8.61%，换手率46.06%，成交量15.06万手，成交额6.45亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出174.77万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000031598.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650070299","title":"万邦医药：本次交易不构成重大资产重组","url":"https://stock-news.laohu8.com/highlight/detail?id=2650070299","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2650070299?lang=zh_cn&edition=full","pubTime":"2026-07-10 15:06","pubTimestamp":1783667178,"startTime":"0","endTime":"0","summary":"证券之星消息，万邦医药(301520)07月09日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司收购赛德盛涉及重组吗？万邦医药回复：尊敬的投资者，您好！本次交易未达到《上市公司重大资产重组管理办法》规定的重大资产重组标准，不构成重大资产重组。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071000021177.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649962554","title":"7月8日万邦医药（301520）龙虎榜数据：机构净卖出17.78万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649962554","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649962554?lang=zh_cn&edition=full","pubTime":"2026-07-08 17:37","pubTimestamp":1783503471,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月8日公布的交易公开信息显示，万邦医药因日换手率达到30%的前5只证券登上龙虎榜。此次是近5个交易日内第5次上榜。截至2026年7月8日收盘，万邦医药报收于42.74元，上涨13.25%，换手率44.88%，成交量14.68万手，成交额5.96亿元。从龙虎榜公布的当日买卖数据来看，机构合计净卖出17.78万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070800031837.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649985703","title":"7月7日万邦医药（301520）龙虎榜数据：机构净买入30.81万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2649985703","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649985703?lang=zh_cn&edition=full","pubTime":"2026-07-07 17:33","pubTimestamp":1783416820,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年7月7日公布的交易公开信息显示，万邦医药因日换手率达到30%的前5只证券登上龙虎榜。此次是近5个交易日内第5次上榜。截至2026年7月7日收盘，万邦医药报收于37.74元，下跌0.76%，换手率40.07%，成交量13.1万手，成交额4.99亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入30.81万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700029922.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649644637","title":"万邦医药：截止2026年6月30日，公司的股东人数为10,730户","url":"https://stock-news.laohu8.com/highlight/detail?id=2649644637","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649644637?lang=zh_cn&edition=full","pubTime":"2026-07-06 15:54","pubTimestamp":1783324446,"startTime":"0","endTime":"0","summary":"证券之星消息，万邦医药(301520)07月06日在投资者关系平台上答复投资者关心的问题。投资者提问：请问，截至2026年六月 30日公司的股东总数是多少？谢谢万邦医药回复：尊敬的投资者您好！截止2026年6月30日，公司的股东人数为10,730户。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600018395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649166406","title":"股市必读：万邦医药（301520）登7月3日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2649166406","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649166406?lang=zh_cn&edition=full","pubTime":"2026-07-06 02:02","pubTimestamp":1783274537,"startTime":"0","endTime":"0","summary":"截至2026年7月3日收盘，万邦医药报收于35.55元，上涨13.22%，换手率41.4%，成交量13.54万手，成交额4.53亿元。当日关注点交易信息汇总：万邦医药7月3日主力资金净流入1619.99万元，游资资金净流入737.63万元，散户资金净流出2357.62万元。交易信息汇总：万邦医药因日换手率达30%登上沪深交易所龙虎榜，系近5个交易日内第4次上榜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600000696.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301520","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648852601","title":"股市必读：万邦医药（301520）登7月1日交易所龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2648852601","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648852601?lang=zh_cn&edition=full","pubTime":"2026-07-02 04:35","pubTimestamp":1782938111,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，万邦医药报收于31.0元，下跌4.62%，换手率36.92%，成交量12.07万手，成交额3.62亿元。当日关注点交易信息汇总：万邦医药因日换手率达30%登上龙虎榜，系近5个交易日内第2次上榜。交易信息汇总资金流向7月1日主力资金净流入274.63万元，占总成交额0.0%；游资资金净流出663.82万元，占总成交额0.0%；散户资金净流入389.2万元，占总成交额0.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200002073.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648511246","title":"万邦医药（301520）披露公司完成收购赛德盛股权工商变更登记，7月1日股价下跌4.62%","url":"https://stock-news.laohu8.com/highlight/detail?id=2648511246","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2648511246?lang=zh_cn&edition=full","pubTime":"2026-07-01 17:55","pubTimestamp":1782899758,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘，万邦医药报收于31.0元，较前一交易日下跌4.62%，最新总市值为28.88亿元。该股当日开盘28.92元，最高31.48元，最低28.63元，成交额达3.62亿元，换手率为36.92%。近日，万邦医药发布股票交易异常波动公告。公告同时指出，公司已于2026年6月30日完成对安徽赛德盛医药科技有限公司75.52%股权的工商变更登记，赛德盛成为公司控股子公司。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070100034883.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647820534","title":"6月30日万邦医药（301520）龙虎榜数据：机构净买入954.57万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2647820534","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647820534?lang=zh_cn&edition=full","pubTime":"2026-06-30 17:47","pubTimestamp":1782812852,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年6月30日公布的交易公开信息显示，万邦医药因日换手率达到30%的前5只证券，连续三个交易日内，涨幅偏离值累计达到30%的证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年6月30日收盘，万邦医药报收于32.5元，上涨15.0%，换手率44.12%，成交量14.43万手，成交额4.73亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入954.57万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000033045.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647588235","title":"【机构调研记录】富安达基金调研奥比中光、万邦医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2647588235","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647588235?lang=zh_cn&edition=full","pubTime":"2026-06-30 08:01","pubTimestamp":1782777694,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及6月29日披露的机构调研信息，富安达基金近期对2家上市公司进行了调研，相关名单如下：1）奥比中光 调研纪要：公司是英伟达全球产业数字化生态布局的重要合作伙伴，多款产品已完成与NVIDIA Jetson Thor等系统级模块的适配与验证，Gemini 335、Gemini 336系列双目3D相机已入驻NVIDIA Isaac Sim机器人仿真开发平台并与Isaac Perceptor集成。2）万邦医药 调研纪要：中国医药研发格局正经历深刻转型，创新药成为增长核心引擎。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000008033.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647588295","title":"【机构调研记录】天治基金调研万邦医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2647588295","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647588295?lang=zh_cn&edition=full","pubTime":"2026-06-30 08:01","pubTimestamp":1782777690,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及6月29日披露的机构调研信息，天治基金近期对1家上市公司进行了调研，相关名单如下：1）万邦医药 调研纪要：中国医药研发格局正经历深刻转型，创新药成为增长核心引擎。旗下最近一年表现最佳的公募基金产品为天治趋势精选混合，最新单位净值为2.04，近一年增长196.77%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000008028.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647884085","title":"【机构调研记录】前海开源基金调研绿联科技、万邦医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2647884085","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647884085?lang=zh_cn&edition=full","pubTime":"2026-06-30 08:01","pubTimestamp":1782777683,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及6月29日披露的机构调研信息，前海开源基金近期对2家上市公司进行了调研，相关名单如下：1）绿联科技 绿联科技2026年一季报显示，一季度公司主营收入27.98亿元，同比上升53.42%；归母净利润2.38亿元，同比上升58.14%；扣非净利润2.32亿元，同比上升62.73%；负债率26.22%，投资收益76.26万元，财务费用2636.92万元，毛利率39.26%。2）万邦医药 调研纪要：中国医药研发格局正经历深刻转型，创新药成为增长核心引擎。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026063000008015.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK0214","301606","301520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647588234","title":"【私募调研记录】中欧瑞博调研万邦医药","url":"https://stock-news.laohu8.com/highlight/detail?id=2647588234","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647588234?lang=zh_cn&edition=full","pubTime":"2026-06-30 08:01","pubTimestamp":1782777660,"startTime":"0","endTime":"0","summary":"根据市场公开信息及6月29日披露的机构调研信息，知名私募中欧瑞博近期对1家上市公司进行了调研，相关名单如下：1）万邦医药 调研纪要：中国医药研发格局正经历深刻转型，创新药成为增长核心引擎。中欧瑞博从事证券私募基金管理业务，专注于二级市场证券投资。取名\"兔子基金\"体现了中欧瑞博敬畏风险的投资文化，并始终把风险防范和管理摆在突出位置。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026063000007968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","301520"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1784529756505,"stockEarnings":[{"period":"1week","weight":0.4745},{"period":"1month","weight":1.7552},{"period":"3month","weight":1.1206},{"period":"6month","weight":1.1173},{"period":"1year","weight":1.0168},{"period":"ytd","weight":1.3635}],"compareEarnings":[{"period":"1week","weight":-0.0581},{"period":"1month","weight":-0.0837},{"period":"3month","weight":-0.0709},{"period":"6month","weight":-0.0823},{"period":"1year","weight":0.0703},{"period":"ytd","weight":-0.0516}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"安徽万邦医药科技股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"17737人(较上一季度增加65.30%)","perCapita":"1843股","listingDate":"2023-09-25","address":"安徽省合肥市蜀山区高新区火龙地路299号","registeredCapital":"9317万元","survey":" 安徽万邦医药科技股份有限公司的主营业务是药学和临床研究一站式服务。公司的主要产品是临床研究服务、药学研究服务。","listedPrice":67.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"万邦医药(301520)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供万邦医药(301520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"万邦医药,301520,万邦医药股票,万邦医药股票老虎,万邦医药股票老虎国际,万邦医药行情,万邦医药股票行情,万邦医药股价,万邦医药股市,万邦医药股票价格,万邦医药股票交易,万邦医药股票购买,万邦医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"万邦医药(301520)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供万邦医药(301520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}